Mol Biol Rep:姜黄素抑制NF-κB信号通路抗乳腺癌转移

2012-07-02 Beyond 生物谷

姜黄素是从姜科、天南星科中的一些植物的根茎中提取的一种化学成分,其中,姜黄约含3%~6%,是植物界很稀少的具有二酮的色素,为二酮类化合物。 近来有报道姜黄素具有抗多种类型癌症的作用,但这种抗癌作用的分子机制尚不完全清楚。最近发表在Molecular Biology Reports杂志上的一项研究中,研究人员评估分析了姜黄素对人类乳腺上皮细胞MCF-7细胞的作用。细胞经姜黄素处理后,MTT法检测肿

姜黄素是从姜科、天南星科中的一些植物的根茎中提取的一种化学成分,其中,姜黄约含3%~6%,是植物界很稀少的具有二酮的色素,为二酮类化合物。

近来有报道姜黄素具有抗多种类型癌症的作用,但这种抗癌作用的分子机制尚不完全清楚。最近发表在Molecular Biology Reports杂志上的一项研究中,研究人员评估分析了姜黄素对人类乳腺上皮细胞MCF-7细胞的作用。细胞经姜黄素处理后,MTT法检测肿瘤细胞活力。采用Transwell小室检测细胞的侵袭能力。NF-κB结合DNA的活性用跨AM NF-κB的ELISA试剂盒对核提取物进行检测。Western印迹检测姜黄素对uPA表达的作用。

研究结果表明姜黄素剂量依赖性地抑制MCF-7细胞增殖。同时,姜黄素处理MCF-7细胞后,其粘附和侵袭能力被大幅抑制。姜黄素也显着下降uPA的表达以及NF-κB的DNA结合活性。研究数据表明姜黄素通过抑制NF-κB的活化下调uPA的表达,拮抗MCF-7细胞的粘附和侵袭。研究人员希望姜黄素对乳腺癌的治疗潜力值得进一步研究。

doi:10.1007/s11033-011-1273-5
PMC:
PMID:

Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways.

Zong H, Wang F, Fan QX, Wang LX.

Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione), is extracted from the plant Curcuma longa. It was recently reported for its anticancer effect on several types of cancer cells in vitro however, the molecular mechanisms of this anticancer effect are not fully understood. In the present study, we evaluated the effects of curcumin on human mammary epithelial carcinoma MCF-7 cells. Cells were treated with curcumin and examined for cell viability by MTT assay. The cells invasion was demonstrated by transwell assay. The binding activity of NF-κB to DNA was examined in nuclear extracts using Trans-AM NF-κB ELISA kit. Western blot was performed to detect the effect of curcumin on the expression of uPA. Our results showed that curcumin dose-dependently inhibited (P < 0.05) the proliferation of MCF-7 cells. Meanwhile, the adhesion and invasion ability of MCF-7 cells were sharply inhibited when treated with different concentrations of curcumin. Curcumin also significantly decreased (P < 0.05) the expression of uPA and NF-κB DNA binding activity, respectively. It is concluded that curcumin inhibits the adhesion and invasion of MCF-7 cells through down-regulating the protein expression of uPA via of NF-κB activation. Accordingly, the therapeutic potential of curcumin for breast cancer deserves further study.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1946224, encodeId=05eb194622416, content=<a href='/topic/show?id=001e12e38b2' target=_blank style='color:#2F92EE;'>#NF-κB信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12738, encryptionId=001e12e38b2, topicName=NF-κB信号通路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Oct 15 15:09:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766792, encodeId=8bc41e667923c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Nov 17 16:09:00 CST 2012, time=2012-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916903, encodeId=505119169030a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat May 11 16:09:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539567, encodeId=8964153956e2a, content=<a href='/topic/show?id=c61a2e315da' target=_blank style='color:#2F92EE;'>#信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27315, encryptionId=c61a2e315da, topicName=信号通路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b12d13147749, createdName=wgx310, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590225, encodeId=c37d159022540, content=<a href='/topic/show?id=2c17e154824' target=_blank style='color:#2F92EE;'>#癌转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71548, encryptionId=2c17e154824, topicName=癌转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dc017794099, createdName=linagood, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1946224, encodeId=05eb194622416, content=<a href='/topic/show?id=001e12e38b2' target=_blank style='color:#2F92EE;'>#NF-κB信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12738, encryptionId=001e12e38b2, topicName=NF-κB信号通路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Oct 15 15:09:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766792, encodeId=8bc41e667923c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Nov 17 16:09:00 CST 2012, time=2012-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916903, encodeId=505119169030a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat May 11 16:09:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539567, encodeId=8964153956e2a, content=<a href='/topic/show?id=c61a2e315da' target=_blank style='color:#2F92EE;'>#信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27315, encryptionId=c61a2e315da, topicName=信号通路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b12d13147749, createdName=wgx310, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590225, encodeId=c37d159022540, content=<a href='/topic/show?id=2c17e154824' target=_blank style='color:#2F92EE;'>#癌转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71548, encryptionId=2c17e154824, topicName=癌转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dc017794099, createdName=linagood, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1946224, encodeId=05eb194622416, content=<a href='/topic/show?id=001e12e38b2' target=_blank style='color:#2F92EE;'>#NF-κB信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12738, encryptionId=001e12e38b2, topicName=NF-κB信号通路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Oct 15 15:09:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766792, encodeId=8bc41e667923c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Nov 17 16:09:00 CST 2012, time=2012-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916903, encodeId=505119169030a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat May 11 16:09:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539567, encodeId=8964153956e2a, content=<a href='/topic/show?id=c61a2e315da' target=_blank style='color:#2F92EE;'>#信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27315, encryptionId=c61a2e315da, topicName=信号通路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b12d13147749, createdName=wgx310, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590225, encodeId=c37d159022540, content=<a href='/topic/show?id=2c17e154824' target=_blank style='color:#2F92EE;'>#癌转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71548, encryptionId=2c17e154824, topicName=癌转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dc017794099, createdName=linagood, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]
    2013-05-11 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=1946224, encodeId=05eb194622416, content=<a href='/topic/show?id=001e12e38b2' target=_blank style='color:#2F92EE;'>#NF-κB信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12738, encryptionId=001e12e38b2, topicName=NF-κB信号通路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Oct 15 15:09:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766792, encodeId=8bc41e667923c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Nov 17 16:09:00 CST 2012, time=2012-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916903, encodeId=505119169030a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat May 11 16:09:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539567, encodeId=8964153956e2a, content=<a href='/topic/show?id=c61a2e315da' target=_blank style='color:#2F92EE;'>#信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27315, encryptionId=c61a2e315da, topicName=信号通路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b12d13147749, createdName=wgx310, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590225, encodeId=c37d159022540, content=<a href='/topic/show?id=2c17e154824' target=_blank style='color:#2F92EE;'>#癌转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71548, encryptionId=2c17e154824, topicName=癌转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dc017794099, createdName=linagood, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1946224, encodeId=05eb194622416, content=<a href='/topic/show?id=001e12e38b2' target=_blank style='color:#2F92EE;'>#NF-κB信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12738, encryptionId=001e12e38b2, topicName=NF-κB信号通路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Oct 15 15:09:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766792, encodeId=8bc41e667923c, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Nov 17 16:09:00 CST 2012, time=2012-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916903, encodeId=505119169030a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat May 11 16:09:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539567, encodeId=8964153956e2a, content=<a href='/topic/show?id=c61a2e315da' target=_blank style='color:#2F92EE;'>#信号通路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27315, encryptionId=c61a2e315da, topicName=信号通路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b12d13147749, createdName=wgx310, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590225, encodeId=c37d159022540, content=<a href='/topic/show?id=2c17e154824' target=_blank style='color:#2F92EE;'>#癌转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71548, encryptionId=2c17e154824, topicName=癌转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dc017794099, createdName=linagood, createdTime=Wed Jul 04 09:09:00 CST 2012, time=2012-07-04, status=1, ipAttribution=)]

相关资讯

Mol Cancer Res:GSK-3或成黑色素瘤治疗新靶点

糖原合成酶激酶-3(glycogen synthase kinase-3,GSK-3)是一种多功能的丝氨酸/苏氨酸蛋白激酶,是细胞内多种信号转导通路中的重要成分,不仅参与细胞内糖代谢过程而且还参与细胞增殖、细胞分化和细胞凋亡等多种重要生理过程。 GSK-3活性受多种机制调节,其活性调节异常时可引起多种重大疾病如糖尿病、神经退行性疾病和肿瘤等。GSK-3已成为许多疾病治疗靶点,目前针对GSK-3靶

Mol Cancer:异黄酮代谢产物抑制血管生成

一直以来某些植物化学物质包括多酚类物质如黄酮类化合物被认为具有抗癌功效。近日,一新研究证实这些化合物通过抑制肿瘤血管生成发挥其保护作用。新研究中发现一种植物化学物质具有潜在的抗血管生成活性,这不仅对了解这些化合物预防肿瘤的作用机制,同时也为开发新的肿瘤治疗试剂铺平了道路。 在试图找出能降低癌症发病率和死亡率的植物化学物质的道路上,研究人员筛选出了一套迄今未经研究过的植物雌激素的代谢产物。在这项新

Mol Cancer Res:TNF-α诱导肾细胞癌上皮间质转化

肿瘤坏死因子的产生-α(TNF-α)主要由活化的单核/巨噬细胞产生,能杀伤和抑制肿瘤细胞的细胞因子。促进中性粒细胞吞噬,抗感染,引起发热,诱导肝细胞急性期蛋白合成,促进髓样白血病细胞向巨噬细胞分化,促进细胞增殖和分化,是重要的炎症介质,并参与某些自身免疫病的病理损伤。 TNF-α是一种具有抗肿瘤特性的细胞因子。而相比之下,肿瘤细胞或基质细胞低剂量地、缓慢生成肿瘤坏死因子可能会促进肿瘤生长和转移。

Cell Mol Life Sci:科学家发现新的炎症治疗目标

称为初级纤毛的微小细胞器是抗击炎症的关键,伦敦玛丽大学的科学家们发现了一种新的抗击炎症的治疗目标。 相关研究论文发表在Cellular and Molecular Life Sciences杂志上,研究人员发现称为初级纤毛的微小细胞器对调节炎症反应很重要。这一发现可能为百万计患有关节炎的人带来潜在的新的治疗方法。 Martin Knight博士说:“虽然初级纤毛已经发现了有一个多世纪前,但我们

Mol Cancer Res:GAS6/Axl信号轴在前列腺癌转移中起关键作用

在多种癌症中受体酪氨酸激酶Axl都过度表达,Axl主要在肿瘤细胞的增殖和侵袭过程中发挥作用。 早期研究数据表明,Axl和其配体生长阻滞特异性因子-6(GAS6)可能在建立有利于肿瘤转移性休眠的骨髓微环境中发挥作用。目前刊登在Molecular Cancer Research杂志上的一则研究中,研究人员发现转移性前列腺癌细胞株PC3和DU145L中Axl是高表达的,低转移性癌细胞系LNCaP中Ax